Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

SHA:600998 Revenue

Jointown Pharmaceutical Group had revenue of 44.78B CNY in the quarter ending March 31, 2026, with 6.58% growth. This brings the company's revenue in the last twelve months to 164.16B, up 7.04% year-over-year. In the year 2025, Jointown Pharmaceutical Group had annual revenue of 161.39B with 6.31% growth.

• Revenue (ttm): 164.16B
• Revenue Growth: +7.04%
• P/S Ratio: 0.14
• Revenue / Employee: 5.50M
• Employees: 29,862
• Market Cap: 23.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	161.39B	9.58B	6.31%
Dec 31, 2024	151.81B	1.67B	1.11%
Dec 31, 2023	150.14B	9.72B	6.92%
Dec 31, 2022	140.42B	18.02B	14.72%
Dec 31, 2021	122.41B	11.55B	10.42%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error